Sigma Healthcare (ASX:SIG) Tariff Resilience Score: 7/10 (As of Jul. 03, 2026)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.79
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Tariff Resilience Score?

Sigma Healthcare ASX:SIG +2.20% 59 Tariff Resilience Score is 7 as of Jul. 03, 2026. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 119 Medical Distribution companies, Sigma Healthcare ranks better than 96.64% on this metric.

Sigma Healthcare has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Sigma Healthcare has Sigma Healthcare has a strong domestic focus in Australia, reducing exposure to international tariffs. However, any imported pharmaceuticals or medical supplies could face tariff risks. The company has some pricing power and alternative supplier options.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sigma Healthcare might have Highly Resilient.

Sigma Healthcare  (ASX:SIG) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sigma Healthcare Tariff Resilience Score Related Terms

ASX:SIG vs MCK, CAH, COR: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, Sigma Healthcare's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma Healthcare Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Tariff Resilience Score falls into.


ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Sigma Healthcare (ASX:SIG) has a Tariff Resilience Score of 7 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Sigma Healthcare ranks #4 out of 119 companies in the Medical Distribution industry, placing it in the top 3.4%.
Is Sigma Healthcare's Tariff Resilience Score too high?
Sigma Healthcare's current Tariff Resilience Score is 7. Based on the distribution chart, Sigma Healthcare ranks #4 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Tariff Resilience Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #4 out of 119 companies for Tariff Resilience Score. This places Sigma Healthcare in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Sigma Healthcare's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.79 — trading 654.1% above its estimated fair value. The current Tariff Resilience Score is 7. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Tariff Resilience Score is 7 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.79 is trading 654.1% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Tariff Resilience Score: 7
  • GF Value™: A$0.37 vs. price of A$2.79 (654.1% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.79
Price
A$0.37
GF Value